[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].
- DOI
- 10.1007/s00115-017-0440-x
- Published
- 2018 Feb
- Container
- Der Nervenarzt
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00115-017-0440-x,
title = {[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].},
author = {Henze T and Feneberg W and Flachenecker P and Seidel D and Albrecht H and Starck M and Meuth SG},
year = {2018},
journal = {Der Nervenarzt},
doi = {10.1007/s00115-017-0440-x},
url = {https://doi.org/10.1007/s00115-017-0440-x}
}RIS
TY - JOUR TI - [What is new in symptomatic MS treatment: Part 3-bladder dysfunction]. AU - Henze T AU - Feneberg W AU - Flachenecker P AU - Seidel D AU - Albrecht H AU - Starck M AU - Meuth SG PY - 2018 JO - Der Nervenarzt DO - 10.1007/s00115-017-0440-x UR - https://doi.org/10.1007/s00115-017-0440-x ER -
APA
T, H., W, F., P, F., D, S., H, A., M, S., & SG, M. (2018). [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].. Der Nervenarzt. https://doi.org/10.1007/s00115-017-0440-x
Source records
- pubmed · retrieved 2026-09-27T16:29:05.179Z